Lipidomics of bioactive lipids in Alzheimer's and Parkinson's diseases: Where are we?

V Chiurchiù, M Tiberi, A Matteocci, F Fazio… - International Journal of …, 2022 - mdpi.com
Lipids are not only constituents of cellular membranes, but they are also key signaling
mediators, thus acting as “bioactive lipids”. Among the prominent roles exerted by bioactive …

[HTML][HTML] Targeting the GBA1 pathway to slow Parkinson disease: Insights into clinical aspects, pathogenic mechanisms and new therapeutic avenues

E Menozzi, M Toffoli, AHV Schapira - Pharmacology & therapeutics, 2023 - Elsevier
The GBA1 gene encodes the lysosomal enzyme glucocerebrosidase (GCase), which is
involved in sphingolipid metabolism. Biallelic variants in GBA1 cause Gaucher disease …

Lipid pathway dysfunction is prevalent in patients with Parkinson's disease

J Galper, NJ Dean, R Pickford, SJG Lewis, GM Halliday… - Brain, 2022 - academic.oup.com
Many genetic risk factors for Parkinson's disease have lipid-related functions and lipid-
modulating drugs such as statins may be protective against Parkinson's disease. Moreover …

'Fly-ing'from rare to common neurodegenerative disease mechanisms

M Ma, MJ Moulton, S Lu, HJ Bellen - Trends in Genetics, 2022 - cell.com
Advances in genome sequencing have enabled researchers and clinicians to probe vast
numbers of human variants to distinguish pathogenic from benign variants. Model …

Glycosphingolipid changes in plasma in Parkinson's disease independent of glucosylceramide levels

D Te Vruchte, A Sturchio, DA Priestman… - Movement …, 2022 - Wiley Online Library
Abstract Background Alteration in glycosphingolipids (GSLs) in Parkinson's disease (PD)
still needs to be determined. Objectives We evaluated if PD subjects show abnormal GSLs …

Identifying FAAH inhibitors as new therapeutic options for the treatment of chronic pain through drug repurposing

A Zanfirescu, G Nitulescu, DP Mihai, GM Nitulescu - Pharmaceuticals, 2021 - mdpi.com
Chronic pain determines a substantial burden on individuals, employers, healthcare
systems, and society. Most of the affected patients report dissatisfaction with currently …

Dry eye in Parkinson's disease: a narrative review

L Ungureanu, KR Chaudhuri, S Diaconu… - Frontiers in …, 2023 - frontiersin.org
In Parkinson's disease (PD) patients, a wide range of ocular and visual disorders are
present. Tear film instability, inflammation and dysfunction of the ocular surface, and the …

Sphingolipid metabolism in brain insulin resistance and neurological diseases

M Mei, M Liu, Y Mei, J Zhao, Y Li - Frontiers in Endocrinology, 2023 - frontiersin.org
Sphingolipids, as members of the large lipid family, are important components of plasma
membrane. Sphingolipids participate in biological signal transduction to regulate various …

Ultra‐Sensitive and Unlabeled SERS Nanosheets for Specific Identification of Glucose in Body Fluids

T Zhang, Y Li, X Lv, S Jiang, S Jiang… - Advanced Functional …, 2024 - Wiley Online Library
The detection of biomolecules utilizing surface‐enhanced Raman spectroscopy (SERS) is
highly trending in research, but the unlabeled and sensitive detection of saccharides in body …

Phosphatidylethanolamine deficiency and triglyceride overload in perilesional cortex contribute to non-goal-directed hyperactivity after traumatic brain injury in mice

L Hahnefeld, A Vogel, R Gurke, G Geisslinger… - Biomedicines, 2022 - mdpi.com
Traumatic brain injury (TBI) is often complicated by long-lasting disabilities, including
headache, fatigue, insomnia, hyperactivity, and cognitive deficits. In a previous study in …